Miravant Pharmaceuticals Report issue

For profit Phase 3
Founded: Goleta CA United States (1987)
Status: Left NME R&D (2005)

Organization Overview

First Clinical Trial
2005
NCT00157976
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now